01.05.2006 | Original Articles
Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer
Erschienen in: Clinical and Translational Oncology | Ausgabe 5/2006
Einloggen, um Zugang zu erhalten